Authors:
Machu, TK
Hamilton, ME
Frye, TF
Shanklin, CL
Harris, MC
Sun, HW
Tenner, JE
Soti, FS
Kem, WR
Citation: Tk. Machu et al., Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine(3A) receptor, J PHARM EXP, 299(3), 2001, pp. 1112-1119
Citation: Wr. Kem, The brain alpha 7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21), BEH BRA RES, 113(1-2), 2000, pp. 169-181
Authors:
Adams, CE
Stevens, KE
Kem, WR
Freedman, R
Citation: Ce. Adams et al., Inhibition of nitric oxide synthase prevents alpha 7 nicotinic receptor-mediated restoration of inhibitory auditory gating in rat hippocampus, BRAIN RES, 877(2), 2000, pp. 235-244
Authors:
van Haaren, F
Anderson, KG
Haworth, SC
Kem, WR
Citation: F. Van Haaren et al., GTS-21, a mixed nicotinic receptor agonist/antagonist, does not affect thenicotine cue, PHARM BIO B, 64(2), 1999, pp. 439-444
Authors:
Pennington, MW
Lanigan, MD
Kalman, K
Mahnir, VM
Rauer, H
McVaugh, CT
Behm, D
Donaldson, D
Chandy, KG
Kem, WR
Norton, RS
Citation: Mw. Pennington et al., Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxin, BIOCHEM, 38(44), 1999, pp. 14549-14558
Authors:
Kalman, K
Pennington, MW
Lanigan, MD
Nguyen, A
Rauer, H
Mahnir, V
Paschetto, K
Kem, WR
Grissmer, S
Gutman, GA
Christian, EP
Cahalan, MD
Norton, RS
Chandy, KG
Citation: K. Kalman et al., ShK-Dap(22), a potent Kv1.3-specific immunosuppressive polypeptide, J BIOL CHEM, 273(49), 1998, pp. 32697-32707